- Published on
Toxicology – Hepatotoxic Drugs and Patterns of Liver Injury
Overview
Drug-induced liver injury can be categorized into three main patterns based on laboratory findings involving alanine aminotransferase (ALT) and alkaline phosphatase (ALP): hepatocellular, cholestatic, and mixed. These patterns help guide diagnosis and management.
Hepatocellular Pattern
This pattern is characterized by a significant elevation in ALT (≥3 times the upper limit of normal [ULN]) with relatively normal ALP levels. The ALT-to-ALP ratio is typically ≥5. It reflects direct liver cell injury and is often associated with inflammation and necrosis.
Cholestatic Pattern
In this pattern, ALP is elevated (≥2 times ULN) while ALT remains near normal. The ALT-to-ALP ratio is low (≤2). It reflects impaired bile flow and is often associated with jaundice, pruritus, and elevated bilirubin levels.
Mixed Pattern
Both ALT and ALP are elevated (ALT ≥3× ULN and ALP ≥2× ULN), with an intermediate ALT-to-ALP ratio (between 2 and 5). This indicates a combination of hepatocellular injury and cholestasis.
Types of Liver Injury
Drug-induced liver injury can present in several forms:
Hepatocellular Necrosis
Common causes include acetaminophen, amatoxins (mushroom poisoning), aspirin, carbamazepine, carbon tetrachloride, iron, isoniazid, methotrexate, methyldopa, phenytoin, phosphorus, quinine, sulfonamides, tetracycline, and vinyl chloride.
Cholestatic Injury
Associated drugs include allopurinol, anabolic steroids (androgens), erythromycin, estrogens, rifampin, tetracycline, and trimethoprim-sulfamethoxazole.
Steatohepatitis
Seen with agents such as aspirin, amiodarone, ketoprofen, methotrexate, tetracycline, and valproic acid.
Granulomatous Hepatitis
Linked to drugs like allopurinol, carbamazepine, diltiazem, halothane, isoniazid, phenytoin, penicillin, procainamide, quinine, quinidine, sulfonamides, and sulfonylureas.
Autoimmune Hepatitis
Can be triggered by medications including dantrolene, diclofenac, methyldopa, nafcillin, nitrofurantoin, and propylthiouracil (PTU).
Key Point
A thorough medication and supplement history is essential in any patient presenting with acute liver dysfunction, as many agents can contribute to hepatotoxicity.
Overview
Drug-induced liver injury can be categorized into three main patterns based on laboratory findings involving alanine aminotransferase (ALT) and alkaline phosphatase (ALP): hepatocellular, cholestatic, and mixed. These patterns help guide diagnosis and management.
Hepatocellular Pattern
This pattern is characterized by a significant elevation in ALT (≥3 times the upper limit of normal [ULN]) with relatively normal ALP levels. The ALT-to-ALP ratio is typically ≥5. It reflects direct liver cell injury and is often associated with inflammation and necrosis.
Cholestatic Pattern
In this pattern, ALP is elevated (≥2 times ULN) while ALT remains near normal. The ALT-to-ALP ratio is low (≤2). It reflects impaired bile flow and is often associated with jaundice, pruritus, and elevated bilirubin levels.
Mixed Pattern
Both ALT and ALP are elevated (ALT ≥3× ULN and ALP ≥2× ULN), with an intermediate ALT-to-ALP ratio (between 2 and 5). This indicates a combination of hepatocellular injury and cholestasis.
Types of Liver Injury
Drug-induced liver injury can present in several forms:
- Hepatocellular necrosis: Characterized by hepatocyte death and markedly elevated transaminases
- Cholestasis: Impaired bile excretion leading to jaundice and itching
- Steatohepatitis: Fat accumulation within liver cells
- Granulomatous hepatitis: Formation of granulomas in liver tissue
- Autoimmune hepatitis: Immune-mediated liver inflammation
Hepatocellular Necrosis
Common causes include acetaminophen, amatoxins (mushroom poisoning), aspirin, carbamazepine, carbon tetrachloride, iron, isoniazid, methotrexate, methyldopa, phenytoin, phosphorus, quinine, sulfonamides, tetracycline, and vinyl chloride.
Cholestatic Injury
Associated drugs include allopurinol, anabolic steroids (androgens), erythromycin, estrogens, rifampin, tetracycline, and trimethoprim-sulfamethoxazole.
Steatohepatitis
Seen with agents such as aspirin, amiodarone, ketoprofen, methotrexate, tetracycline, and valproic acid.
Granulomatous Hepatitis
Linked to drugs like allopurinol, carbamazepine, diltiazem, halothane, isoniazid, phenytoin, penicillin, procainamide, quinine, quinidine, sulfonamides, and sulfonylureas.
Autoimmune Hepatitis
Can be triggered by medications including dantrolene, diclofenac, methyldopa, nafcillin, nitrofurantoin, and propylthiouracil (PTU).
Key Point
A thorough medication and supplement history is essential in any patient presenting with acute liver dysfunction, as many agents can contribute to hepatotoxicity.
- Published on
Toxicology – Ototoxic Drugs
Overview
Ototoxic medications can damage the inner ear, affecting either the cochlea (leading to sensorineural hearing loss), the vestibular system (causing balance disturbances), or both.
Clinical Features
Patients may present with hearing impairment, ringing in the ears (tinnitus), or problems with balance and coordination (disequilibrium). Symptoms can vary depending on whether cochlear or vestibular structures are involved.
Common Drug Classes
Medications known to cause ototoxicity include aminoglycoside antibiotics, loop diuretics, nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, platinum-based chemotherapeutic agents, quinidine, quinine, salicylates, tetracyclines, and valproic acid.
Management
The primary approach is prompt discontinuation of the offending agent when possible. Patients should be referred for evaluation by an ear, nose, and throat (ENT) specialist and audiology testing to assess the extent of hearing or balance dysfunction.
Overview
Ototoxic medications can damage the inner ear, affecting either the cochlea (leading to sensorineural hearing loss), the vestibular system (causing balance disturbances), or both.
Clinical Features
Patients may present with hearing impairment, ringing in the ears (tinnitus), or problems with balance and coordination (disequilibrium). Symptoms can vary depending on whether cochlear or vestibular structures are involved.
Common Drug Classes
Medications known to cause ototoxicity include aminoglycoside antibiotics, loop diuretics, nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, platinum-based chemotherapeutic agents, quinidine, quinine, salicylates, tetracyclines, and valproic acid.
Management
The primary approach is prompt discontinuation of the offending agent when possible. Patients should be referred for evaluation by an ear, nose, and throat (ENT) specialist and audiology testing to assess the extent of hearing or balance dysfunction.
- Published on
Toxicology – Pancreatitis and Pancreatic Toxins
Overview
Pancreatitis is inflammation of the pancreas with multiple possible causes. While many cases are due to common conditions like gallstones and alcohol use, toxins, drugs, and metabolic abnormalities also play significant roles.
Common Causes
Gallstones
Gallstones are one of the leading causes of pancreatitis and, together with alcohol, account for the majority of cases.
Ethanol (Alcohol)
Alcohol is a major contributor to both acute and chronic pancreatitis due to its direct toxic effects on pancreatic cells.
Idiopathic
In some cases, no clear cause can be identified despite thorough evaluation.
Trauma
Blunt or penetrating injury to the abdomen can damage the pancreas and trigger inflammation.
Steroids and Hormones
Both corticosteroids and certain hormonal therapies have been associated with pancreatitis.
Infections
Viruses such as mumps, cytomegalovirus (CMV), and coxsackievirus can lead to pancreatic inflammation.
Malignancy
Pancreatic cancer may present with or contribute to pancreatitis and generally carries a poor prognosis.
Autoimmune Causes
Autoimmune pancreatitis is a form of chronic inflammation that often responds well to steroid therapy.
Scorpion Envenomation
Although uncommon, scorpion stings have been reported to trigger pancreatitis.
Metabolic Causes
Hypercalcemia
Elevated calcium levels, often due to hyperparathyroidism, can precipitate pancreatitis.
Hypertriglyceridemia
Very high triglyceride levels (typically >1,000 mg/dL) are a well-recognized cause.
Procedural Causes
Post-ERCP
Pancreatitis may occur after endoscopic retrograde cholangiopancreatography (ERCP), with a notable incidence in clinical practice.
Drug-Induced Pancreatitis
Common Drug Classes
Corticosteroids, antiretroviral (HIV) medications, chemotherapeutic agents, and thiazide diuretics are associated with pancreatic inflammation.
Specific Medications
Drugs known to cause pancreatitis include azathioprine, carbamazepine, cisplatin, didanosine, lamivudine, mercaptopurine, mesalamine, pentamidine, sulindac, tetracycline, valproic acid, and steroids.
Overview
Pancreatitis is inflammation of the pancreas with multiple possible causes. While many cases are due to common conditions like gallstones and alcohol use, toxins, drugs, and metabolic abnormalities also play significant roles.
Common Causes
Gallstones
Gallstones are one of the leading causes of pancreatitis and, together with alcohol, account for the majority of cases.
Ethanol (Alcohol)
Alcohol is a major contributor to both acute and chronic pancreatitis due to its direct toxic effects on pancreatic cells.
Idiopathic
In some cases, no clear cause can be identified despite thorough evaluation.
Trauma
Blunt or penetrating injury to the abdomen can damage the pancreas and trigger inflammation.
Steroids and Hormones
Both corticosteroids and certain hormonal therapies have been associated with pancreatitis.
Infections
Viruses such as mumps, cytomegalovirus (CMV), and coxsackievirus can lead to pancreatic inflammation.
Malignancy
Pancreatic cancer may present with or contribute to pancreatitis and generally carries a poor prognosis.
Autoimmune Causes
Autoimmune pancreatitis is a form of chronic inflammation that often responds well to steroid therapy.
Scorpion Envenomation
Although uncommon, scorpion stings have been reported to trigger pancreatitis.
Metabolic Causes
Hypercalcemia
Elevated calcium levels, often due to hyperparathyroidism, can precipitate pancreatitis.
Hypertriglyceridemia
Very high triglyceride levels (typically >1,000 mg/dL) are a well-recognized cause.
Procedural Causes
Post-ERCP
Pancreatitis may occur after endoscopic retrograde cholangiopancreatography (ERCP), with a notable incidence in clinical practice.
Drug-Induced Pancreatitis
Common Drug Classes
Corticosteroids, antiretroviral (HIV) medications, chemotherapeutic agents, and thiazide diuretics are associated with pancreatic inflammation.
Specific Medications
Drugs known to cause pancreatitis include azathioprine, carbamazepine, cisplatin, didanosine, lamivudine, mercaptopurine, mesalamine, pentamidine, sulindac, tetracycline, valproic acid, and steroids.
- Published on
Toxicology – Nephrotoxins and Acute Kidney Injury
Overview
Acute kidney injury (AKI) can be categorized into three major types based on the underlying cause: prerenal, intrinsic, and postrenal. Identifying the category helps guide diagnosis and management.
Prerenal Causes
These result from decreased renal perfusion. Common examples include hypotension, dehydration, and narrowing of the renal arteries.
Intrinsic Causes
These involve direct damage to kidney structures. Examples include glomerulonephritis, acute tubular necrosis (ATN), and acute interstitial nephritis.
Postrenal Causes
These are due to obstruction of urine flow, such as kidney stones, tumors, benign prostatic hyperplasia (BPH), or other urinary tract blockages.
Toxic Acute Tubular Necrosis (ATN)
Chemical and Environmental Exposures
Pesticides, iodinated contrast agents, and organic solvents such as carbon tetrachloride and chloroform can directly damage renal tubules.
Pigment-Related Injury
Hemoglobin from hemolysis and myoglobin from rhabdomyolysis can accumulate in renal tubules, leading to kidney injury.
Toxic Alcohols
Substances like ethylene glycol and methanol can cause severe renal damage through toxic metabolites.
Heavy Metals
Metals such as mercury, arsenic, lead, chromium, gold, and cadmium are known nephrotoxins.
Paraproteinemia
Bence Jones proteins, often seen in multiple myeloma, can damage renal tubules and impair function.
Medications and Substances
Drugs such as aminoglycosides, acyclovir, cidofovir, indinavir, cisplatin, cyclosporine, tacrolimus, and NSAIDs are commonly implicated. Certain herbal toxins (e.g., aristolochic acid) and foods like star fruit have also been associated with nephrotoxicity.
Ischemic Acute Tubular Necrosis
This form of ATN results from reduced blood flow and oxygen delivery to the kidneys. Causes include shock, severe burns, trauma, sepsis, pancreatitis, liver cirrhosis, renal artery embolism, and disseminated intravascular coagulation. It may also occur with conditions such as hypercalcemia, tumor lysis syndrome (hyperuricemia), phosphate nephropathy, and exposure to medications like ACE inhibitors, ARBs, mannitol, and NSAIDs.
Overview
Acute kidney injury (AKI) can be categorized into three major types based on the underlying cause: prerenal, intrinsic, and postrenal. Identifying the category helps guide diagnosis and management.
Prerenal Causes
These result from decreased renal perfusion. Common examples include hypotension, dehydration, and narrowing of the renal arteries.
Intrinsic Causes
These involve direct damage to kidney structures. Examples include glomerulonephritis, acute tubular necrosis (ATN), and acute interstitial nephritis.
Postrenal Causes
These are due to obstruction of urine flow, such as kidney stones, tumors, benign prostatic hyperplasia (BPH), or other urinary tract blockages.
Toxic Acute Tubular Necrosis (ATN)
Chemical and Environmental Exposures
Pesticides, iodinated contrast agents, and organic solvents such as carbon tetrachloride and chloroform can directly damage renal tubules.
Pigment-Related Injury
Hemoglobin from hemolysis and myoglobin from rhabdomyolysis can accumulate in renal tubules, leading to kidney injury.
Toxic Alcohols
Substances like ethylene glycol and methanol can cause severe renal damage through toxic metabolites.
Heavy Metals
Metals such as mercury, arsenic, lead, chromium, gold, and cadmium are known nephrotoxins.
Paraproteinemia
Bence Jones proteins, often seen in multiple myeloma, can damage renal tubules and impair function.
Medications and Substances
Drugs such as aminoglycosides, acyclovir, cidofovir, indinavir, cisplatin, cyclosporine, tacrolimus, and NSAIDs are commonly implicated. Certain herbal toxins (e.g., aristolochic acid) and foods like star fruit have also been associated with nephrotoxicity.
Ischemic Acute Tubular Necrosis
This form of ATN results from reduced blood flow and oxygen delivery to the kidneys. Causes include shock, severe burns, trauma, sepsis, pancreatitis, liver cirrhosis, renal artery embolism, and disseminated intravascular coagulation. It may also occur with conditions such as hypercalcemia, tumor lysis syndrome (hyperuricemia), phosphate nephropathy, and exposure to medications like ACE inhibitors, ARBs, mannitol, and NSAIDs.
- Published on
Toxicology – Marijuana (Cannabis)
Source
Marijuana is derived from the female Cannabis plant and can be used in various forms, including smoking, ingestion, or as a brewed preparation.
Typical Presentation
A common scenario involves recreational use in social settings, leading to feelings of relaxation, euphoria, altered perception, and impaired coordination. Users may describe changes in time perception and sensory experiences.
Clinical Features
Psychological effects include euphoria, calmness, altered perception, impaired attention, decreased concentration, and possible hallucinations. Physical findings may include increased heart rate, elevated blood pressure, dry mouth, rapid breathing, red eyes (conjunctival injection), and increased appetite. Coordination and motor function may also be impaired.
Mechanism of Action
The primary psychoactive component, delta-9-tetrahydrocannabinol (THC), is highly lipophilic and rapidly absorbed, with peak levels occurring shortly after inhalation. THC acts on cannabinoid receptors (CB1 in the central nervous system and CB2 in peripheral tissues), modulating neurotransmitter release. Due to its fat solubility, THC accumulates in adipose tissue and may remain detectable for extended periods, especially in frequent users.
Management
Treatment is supportive. Reassurance is often sufficient, and benzodiazepines may be used for significant anxiety or agitation.
Key Points
Source
Marijuana is derived from the female Cannabis plant and can be used in various forms, including smoking, ingestion, or as a brewed preparation.
Typical Presentation
A common scenario involves recreational use in social settings, leading to feelings of relaxation, euphoria, altered perception, and impaired coordination. Users may describe changes in time perception and sensory experiences.
Clinical Features
Psychological effects include euphoria, calmness, altered perception, impaired attention, decreased concentration, and possible hallucinations. Physical findings may include increased heart rate, elevated blood pressure, dry mouth, rapid breathing, red eyes (conjunctival injection), and increased appetite. Coordination and motor function may also be impaired.
Mechanism of Action
The primary psychoactive component, delta-9-tetrahydrocannabinol (THC), is highly lipophilic and rapidly absorbed, with peak levels occurring shortly after inhalation. THC acts on cannabinoid receptors (CB1 in the central nervous system and CB2 in peripheral tissues), modulating neurotransmitter release. Due to its fat solubility, THC accumulates in adipose tissue and may remain detectable for extended periods, especially in frequent users.
Management
Treatment is supportive. Reassurance is often sufficient, and benzodiazepines may be used for significant anxiety or agitation.
Key Points
- Cannabis can be consumed by smoking, ingestion, or brewing into beverages.
- Oral use has a delayed onset (typically 1–3 hours) and may lead to stronger or unpredictable effects.
- Marijuana may sometimes be contaminated with other substances such as PCP or stimulants.
- Substances marketed as “formaldehyde-treated” marijuana are often actually contaminated with PCP rather than formaldehyde itself.
- Published on
Toxicology – Cardiac Physiology (Key Mechanisms)
Beta-Adrenergic Activation
Beta-agonists bind to β-receptors on cardiac cells, leading to activation of intracellular G proteins that initiate downstream signaling.
Adenylyl Cyclase Activation
The activated G protein stimulates adenylyl cyclase, an enzyme that converts ATP into cyclic AMP (cAMP), a key second messenger.
Glucagon Pathway
Glucagon can independently stimulate adenylyl cyclase, increasing cAMP levels through an alternative (“bypass”) pathway that does not rely on β-receptors.
Calcium Influx
Elevated cAMP activates protein kinase A, which enhances calcium channel opening and increases intracellular calcium entry, strengthening cardiac contraction.
cAMP Breakdown
cAMP is eventually degraded into inactive 5′-AMP by phosphodiesterase enzymes, terminating its effects.
Digitalis Effect
Digitalis inhibits the Na⁺/K⁺-ATPase pump, leading to increased intracellular sodium and secondary rise in intracellular calcium, which enhances cardiac contractility.
Key Points
Beta-Adrenergic Activation
Beta-agonists bind to β-receptors on cardiac cells, leading to activation of intracellular G proteins that initiate downstream signaling.
Adenylyl Cyclase Activation
The activated G protein stimulates adenylyl cyclase, an enzyme that converts ATP into cyclic AMP (cAMP), a key second messenger.
Glucagon Pathway
Glucagon can independently stimulate adenylyl cyclase, increasing cAMP levels through an alternative (“bypass”) pathway that does not rely on β-receptors.
Calcium Influx
Elevated cAMP activates protein kinase A, which enhances calcium channel opening and increases intracellular calcium entry, strengthening cardiac contraction.
cAMP Breakdown
cAMP is eventually degraded into inactive 5′-AMP by phosphodiesterase enzymes, terminating its effects.
Digitalis Effect
Digitalis inhibits the Na⁺/K⁺-ATPase pump, leading to increased intracellular sodium and secondary rise in intracellular calcium, which enhances cardiac contractility.
Key Points
- Beta-blockers inhibit β-adrenergic receptors, reducing cardiac stimulation.
- Glucagon is useful in beta-blocker overdose because it increases cAMP independently of β-receptors.
- Calcium channel blockers reduce calcium entry into cells, decreasing contractility and conduction.
- Phosphodiesterase inhibitors increase cAMP levels, thereby promoting calcium influx and enhancing cardiac function.
- Published on
Toxicology – Non-Anion Gap Metabolic Acidosis (HARD UP)
Hyperalimentation (TPN)
Total parenteral nutrition with excessive chloride content can result in hyperchloremic metabolic acidosis. Management involves reducing chloride and increasing acetate in the formulation. Regular monitoring with daily basic metabolic panels is important in these patients.
Acetazolamide
Acetazolamide inhibits carbonic anhydrase in the proximal tubule, leading to increased urinary bicarbonate loss and a non-anion gap metabolic acidosis. Patients may experience paresthesias in the extremities and a metallic taste.
Renal Tubular Acidosis (RTA)
Renal tubular dysfunction impairs acid and ammonia excretion, resulting in hyperchloremic metabolic acidosis. It is classified into Type I (distal, hypokalemic), Type II (proximal, hypokalemic), and Type IV (hyperkalemic). Type III is no longer recognized as a separate entity.
Diarrhea
Loss of bicarbonate through the gastrointestinal tract leads to non-anion gap metabolic acidosis. Treatment includes intravenous fluids and bicarbonate replacement.
Ureteroenteric Fistula
This condition can cause metabolic acidosis through several mechanisms: reabsorption of ammonium chloride from urine, exchange of chloride for bicarbonate in the bowel, and renal tubular impairment. Risk increases with prolonged urine exposure to bowel mucosa and greater surface area involvement.
Pancreaticoduodenal Fistula
Similar to diarrhea, this condition leads to bicarbonate loss and subsequent non-anion gap metabolic acidosis. Management focuses on fluid resuscitation and correction of electrolyte imbalances.
Hyperalimentation (TPN)
Total parenteral nutrition with excessive chloride content can result in hyperchloremic metabolic acidosis. Management involves reducing chloride and increasing acetate in the formulation. Regular monitoring with daily basic metabolic panels is important in these patients.
Acetazolamide
Acetazolamide inhibits carbonic anhydrase in the proximal tubule, leading to increased urinary bicarbonate loss and a non-anion gap metabolic acidosis. Patients may experience paresthesias in the extremities and a metallic taste.
Renal Tubular Acidosis (RTA)
Renal tubular dysfunction impairs acid and ammonia excretion, resulting in hyperchloremic metabolic acidosis. It is classified into Type I (distal, hypokalemic), Type II (proximal, hypokalemic), and Type IV (hyperkalemic). Type III is no longer recognized as a separate entity.
Diarrhea
Loss of bicarbonate through the gastrointestinal tract leads to non-anion gap metabolic acidosis. Treatment includes intravenous fluids and bicarbonate replacement.
Ureteroenteric Fistula
This condition can cause metabolic acidosis through several mechanisms: reabsorption of ammonium chloride from urine, exchange of chloride for bicarbonate in the bowel, and renal tubular impairment. Risk increases with prolonged urine exposure to bowel mucosa and greater surface area involvement.
Pancreaticoduodenal Fistula
Similar to diarrhea, this condition leads to bicarbonate loss and subsequent non-anion gap metabolic acidosis. Management focuses on fluid resuscitation and correction of electrolyte imbalances.
- Published on
Toxicology – Drugs Causing Hypoventilation
Opiates
Opiates are the most significant contributors to respiratory depression among toxicologic agents. They suppress the brainstem respiratory center, leading to decreased respiratory rate and depth. Reversal with naloxone is effective but should be carefully titrated to avoid precipitating acute withdrawal.
Sedative–Hypnotics
This class of central nervous system depressants reduces respiratory drive in overdose situations, potentially leading to hypoventilation and respiratory failure.
Liquor (Ethanol)
At very high concentrations, ethanol can cause marked central nervous system depression, resulting in clinically significant respiratory suppression.
Weed (Cannabinoids)
Cannabinoid receptor agonists such as marijuana generally have mild respiratory effects. However, slight reductions in respiratory rate may occur as part of overall central nervous system depression.
Treatment
In patients with decreased consciousness, central nervous system depression, or inadequate ventilation, airway protection with endotracheal intubation is essential. Opiate toxicity can be reversed with naloxone, and continuous infusion may be required due to its shorter duration of action compared to many opioids. Flumazenil may reverse certain sedative–hypnotics like benzodiazepines, but it must be used cautiously as it can trigger withdrawal seizures or status epilepticus in dependent individuals.
Opiates
Opiates are the most significant contributors to respiratory depression among toxicologic agents. They suppress the brainstem respiratory center, leading to decreased respiratory rate and depth. Reversal with naloxone is effective but should be carefully titrated to avoid precipitating acute withdrawal.
Sedative–Hypnotics
This class of central nervous system depressants reduces respiratory drive in overdose situations, potentially leading to hypoventilation and respiratory failure.
Liquor (Ethanol)
At very high concentrations, ethanol can cause marked central nervous system depression, resulting in clinically significant respiratory suppression.
Weed (Cannabinoids)
Cannabinoid receptor agonists such as marijuana generally have mild respiratory effects. However, slight reductions in respiratory rate may occur as part of overall central nervous system depression.
Treatment
In patients with decreased consciousness, central nervous system depression, or inadequate ventilation, airway protection with endotracheal intubation is essential. Opiate toxicity can be reversed with naloxone, and continuous infusion may be required due to its shorter duration of action compared to many opioids. Flumazenil may reverse certain sedative–hypnotics like benzodiazepines, but it must be used cautiously as it can trigger withdrawal seizures or status epilepticus in dependent individuals.
- Published on
Toxicology – Drugs Causing Bradycardia
Beta-Blockers (e.g., Propranolol)
Beta-blockers reduce sinoatrial (SA) and atrioventricular (AV) nodal conduction, leading to decreased heart rate and, in severe cases, heart block.
Opiates (Poppies)
Opiates increase vagal tone and exert a depressant effect on SA and AV nodal conduction, contributing to bradycardia.
Anticholinesterase Inhibitors
By inhibiting acetylcholinesterase, these agents increase acetylcholine levels, producing a cholinergic toxidrome in which bradycardia is a prominent feature.
Clonidine
Clonidine is a central α₂ receptor agonist that can cause bradycardia along with hypotension and respiratory depression.
Calcium Channel Blockers
These medications impair SA and AV nodal conduction, resulting in decreased heart rate and potential heart block.
Digoxin
Digoxin increases vagal tone while slowing conduction through the SA and AV nodes, leading to bradycardia despite its positive inotropic effects.
Ethanol
At high doses, ethanol can depress cardiac function and contribute to bradycardia.
Treatment
Atropine may be administered to counteract increased vagal tone and raise heart rate. If ineffective, external pacing should be considered. Definitive management involves identifying the causative toxin and administering the appropriate antidote or targeted therapy.
Beta-Blockers (e.g., Propranolol)
Beta-blockers reduce sinoatrial (SA) and atrioventricular (AV) nodal conduction, leading to decreased heart rate and, in severe cases, heart block.
Opiates (Poppies)
Opiates increase vagal tone and exert a depressant effect on SA and AV nodal conduction, contributing to bradycardia.
Anticholinesterase Inhibitors
By inhibiting acetylcholinesterase, these agents increase acetylcholine levels, producing a cholinergic toxidrome in which bradycardia is a prominent feature.
Clonidine
Clonidine is a central α₂ receptor agonist that can cause bradycardia along with hypotension and respiratory depression.
Calcium Channel Blockers
These medications impair SA and AV nodal conduction, resulting in decreased heart rate and potential heart block.
Digoxin
Digoxin increases vagal tone while slowing conduction through the SA and AV nodes, leading to bradycardia despite its positive inotropic effects.
Ethanol
At high doses, ethanol can depress cardiac function and contribute to bradycardia.
Treatment
Atropine may be administered to counteract increased vagal tone and raise heart rate. If ineffective, external pacing should be considered. Definitive management involves identifying the causative toxin and administering the appropriate antidote or targeted therapy.
- Published on
Toxicology – Drugs Causing Tachycardia
Cocaine (Freebase)
Cocaine produces strong sympathomimetic effects by blocking the reuptake of serotonin, dopamine, and norepinephrine, leading to increased heart rate and blood pressure.
Amphetamines
Amphetamines stimulate the release of catecholamines from presynaptic nerve terminals, resulting in marked tachycardia and hypertension.
Sympathomimetics
This group of drugs elevates heart rate and blood pressure by increasing catecholamine release, decreasing reuptake, or inhibiting metabolism.
Anticholinergics
Anticholinergic agents inhibit parasympathetic activity, causing an increase in heart rate and often accompanying hypertension.
Antihistamines
Many antihistamines possess anticholinergic properties, which can lead to tachycardia as part of their toxic effects.
Theophylline (Methylxanthines)
Theophylline acts as an adenosine receptor antagonist, β-agonist, and phosphodiesterase inhibitor, all of which contribute to increased heart rate and potential arrhythmias.
Thyroid Hormone
Excess thyroid hormone elevates metabolic rate and enhances sensitivity to catecholamines, leading to tachycardia.
Solvents (Inhalants)
Inhaled solvents may displace oxygen in the lungs, causing hypoxemia and reflex tachycardia. They can also sensitize the myocardium to catecholamines, increasing the risk of fatal arrhythmias.
Fever
An increase in body temperature raises basal metabolic rate, which in turn increases heart rate.
Treatment
Benzodiazepines are the first-line treatment for undifferentiated tachycardia in toxicologic settings. Intravenous fluids should be administered in cases of hypovolemia, and active cooling measures should be initiated for patients with hyperthermia.
Cocaine (Freebase)
Cocaine produces strong sympathomimetic effects by blocking the reuptake of serotonin, dopamine, and norepinephrine, leading to increased heart rate and blood pressure.
Amphetamines
Amphetamines stimulate the release of catecholamines from presynaptic nerve terminals, resulting in marked tachycardia and hypertension.
Sympathomimetics
This group of drugs elevates heart rate and blood pressure by increasing catecholamine release, decreasing reuptake, or inhibiting metabolism.
Anticholinergics
Anticholinergic agents inhibit parasympathetic activity, causing an increase in heart rate and often accompanying hypertension.
Antihistamines
Many antihistamines possess anticholinergic properties, which can lead to tachycardia as part of their toxic effects.
Theophylline (Methylxanthines)
Theophylline acts as an adenosine receptor antagonist, β-agonist, and phosphodiesterase inhibitor, all of which contribute to increased heart rate and potential arrhythmias.
Thyroid Hormone
Excess thyroid hormone elevates metabolic rate and enhances sensitivity to catecholamines, leading to tachycardia.
Solvents (Inhalants)
Inhaled solvents may displace oxygen in the lungs, causing hypoxemia and reflex tachycardia. They can also sensitize the myocardium to catecholamines, increasing the risk of fatal arrhythmias.
Fever
An increase in body temperature raises basal metabolic rate, which in turn increases heart rate.
Treatment
Benzodiazepines are the first-line treatment for undifferentiated tachycardia in toxicologic settings. Intravenous fluids should be administered in cases of hypovolemia, and active cooling measures should be initiated for patients with hyperthermia.
